Revised CTIS transparency rules applicable as from 18 June 2024 introduce simplifications to provide access to clinical trial information in a faster and more efficient way. A key change is the removal of the deferral mechanism, which allowed sponsors to delay the publication of certain data and documents to protect commercially confidential information (CCI).